These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 11396966)
1. Differential N-demethylation of l-alpha-acetylmethadol (LAAM) and norLAAM by cytochrome P450s 2B6, 2C18, and 3A4. Neff JA; Moody DE Biochem Biophys Res Commun; 2001 Jun; 284(3):751-6. PubMed ID: 11396966 [TBL] [Abstract][Full Text] [Related]
2. The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone. Moody DE; Alburges ME; Parker RJ; Collins JM; Strong JM Drug Metab Dispos; 1997 Dec; 25(12):1347-53. PubMed ID: 9394023 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of levo-alpha-Acetylmethadol (LAAM) by human liver cytochrome P450: involvement of CYP3A4 characterized by atypical kinetics with two binding sites. Oda Y; Kharasch ED J Pharmacol Exp Ther; 2001 Apr; 297(1):410-22. PubMed ID: 11259570 [TBL] [Abstract][Full Text] [Related]
4. Determination of l-alpha-acetylmethadol (LAAM), norLAAM, and dinorLAAM in clinical and in vitro samples using liquid chromatography with electrospray ionization and tandem mass spectrometry. Huang W; Bemis PA; Slawson MH; Moody DE J Pharm Sci; 2003 Jan; 92(1):10-20. PubMed ID: 12486677 [TBL] [Abstract][Full Text] [Related]
5. Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studies. Kharasch ED; Whittington D; Hoffer C; Krudys K; Craig K; Vicini P; Sheffels P; Lalovic B Clin Pharmacokinet; 2005; 44(7):731-51. PubMed ID: 15966756 [TBL] [Abstract][Full Text] [Related]
6. Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily. Ono S; Hatanaka T; Miyazawa S; Tsutsui M; Aoyama T; Gonzalez FJ; Satoh T Xenobiotica; 1996 Nov; 26(11):1155-66. PubMed ID: 8948091 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18. Minoletti C; Dijols S; Dansette PM; Mansuy D Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023 [TBL] [Abstract][Full Text] [Related]
8. N-demethylation of levo-alpha-acetylmethadol by human placental aromatase. Deshmukh SV; Nanovskaya TN; Hankins GD; Ahmed MS Biochem Pharmacol; 2004 Mar; 67(5):885-92. PubMed ID: 15104241 [TBL] [Abstract][Full Text] [Related]
9. Ketoconazole, a cytochrome P450 3A4 inhibitor, markedly increases concentrations of levo-acetyl-alpha-methadol in opioid-naive individuals. Moody DE; Walsh SL; Rollins DE; Neff JA; Huang W Clin Pharmacol Ther; 2004 Aug; 76(2):154-66. PubMed ID: 15289792 [TBL] [Abstract][Full Text] [Related]
10. Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation. Chang Y; Fang WB; Lin SN; Moody DE Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):55-62. PubMed ID: 20825389 [TBL] [Abstract][Full Text] [Related]
11. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Iribarne C; Berthou F; Baird S; Dréano Y; Picart D; Bail JP; Beaune P; Ménez JF Chem Res Toxicol; 1996 Mar; 9(2):365-73. PubMed ID: 8839037 [TBL] [Abstract][Full Text] [Related]
12. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Marill J; Cresteil T; Lanotte M; Chabot GG Mol Pharmacol; 2000 Dec; 58(6):1341-8. PubMed ID: 11093772 [TBL] [Abstract][Full Text] [Related]
13. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Yamazaki H; Shaw PM; Guengerich FP; Shimada T Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734 [TBL] [Abstract][Full Text] [Related]
14. Variables in human liver microsome preparation: impact on the kinetics of l-alpha-acetylmethadol (LAAM) n-demethylation and dextromethorphan O-demethylation. Nelson AC; Huang W; Moody DE Drug Metab Dispos; 2001 Mar; 29(3):319-25. PubMed ID: 11181502 [TBL] [Abstract][Full Text] [Related]
15. Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Roy P; Yu LJ; Crespi CL; Waxman DJ Drug Metab Dispos; 1999 Jun; 27(6):655-66. PubMed ID: 10348794 [TBL] [Abstract][Full Text] [Related]
16. A gas chromatographic-positive ion chemical ionization-mass spectrometric method for the determination of I-alpha-acetylmethadol (LAAM), norLAAM, and dinorLAAM in plasma, urine, and tissue. Moody DE; Crouch DJ; Sakashita CO; Alburges ME; Minear K; Schulthies JE; Foltz RL J Anal Toxicol; 1995 Oct; 19(6):343-51. PubMed ID: 8926727 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation. Oda Y; Kharasch ED J Pharmacol Exp Ther; 2001 Sep; 298(3):1021-32. PubMed ID: 11504799 [TBL] [Abstract][Full Text] [Related]
18. Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Yamazaki H; Inoue K; Hashimoto M; Shimada T Arch Toxicol; 1999 Mar; 73(2):65-70. PubMed ID: 10350185 [TBL] [Abstract][Full Text] [Related]
19. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5. Lin HL; Kent UM; Hollenberg PF J Pharmacol Exp Ther; 2005 Apr; 313(1):154-64. PubMed ID: 15608076 [TBL] [Abstract][Full Text] [Related]
20. Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs. Mancy A; Antignac M; Minoletti C; Dijols S; Mouries V; Duong NT; Battioni P; Dansette PM; Mansuy D Biochemistry; 1999 Oct; 38(43):14264-70. PubMed ID: 10572000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]